Previous 10 | Next 10 |
NORTHAMPTON, MA / ACCESSWIRE / August 28, 2023 / Alkermes Equality for women matters every day, and at Alkermes we're proud to empower our female colleagues across the organization. In the life sciences industry, striving for gender equality means envisioning a future where the upcoming generat...
2023-08-24 17:36:46 ET Summary Alkermes to split neuroscience and oncology divisions; strong growth with drug Lybalvi highlighted. Financials show robust growth; concerns include a projected 2024 revenue dip and Vivitrol litigation. Recommendation: "Buy" due to neuro portfolio...
NORTHAMPTON, MA / ACCESSWIRE / August 21, 2023 / Alkermes On many college campuses, back to school can also mean an increase in alcohol consumption. If you have a loved one heading back to school, it's important to speak to them about the dangers of alcohol abuse. Here are some facts from The...
2023-08-10 05:21:00 ET If you look at the S&P 500 , which is up more than 18% this year, or the Nasdaq Composite , which is up more than 34% in 2023, it appears the markets are booming. If you look specifically at biotech stocks, it appears they are still caught up in a down...
2023-07-26 12:12:05 ET Alkermes plc (ALKS) Q2 2023 Earnings Conference Call July 26, 2023 8:00 AM ET Company Participants Sandra Coombs – Senior Vice President-Corporate Affairs and Investor Relations Iain Brown – Chief Financial Officer Todd Nichol...
2023-07-26 07:07:10 ET Alkermes press release ( NASDAQ: ALKS ): Q2 Non-GAAP EPS of $0.55 misses by $0.09 . Revenue of $617.4M (+123.5% Y/Y) beats by $134.27M . Second Quarter Revenues of $617.4 Million Reflect Strong Performance of Proprietary Product...
Alkermes plc Reports Second Quarter 2023 Financial Results PR Newswire — Second Quarter Revenues of $617.4 Million Reflect Strong Performance of Proprietary Product Portfolio and Reinstatement of Long-Acting INVEGA ® Product Royalties — &...
2023-07-25 14:12:30 ET Alkermes ( NASDAQ: ALKS ) is scheduled to announce Q2 earnings results on Wednesday, July 26th, before market open. The consensus EPS Estimate is $0.64 (+966.7% Y/Y) and the consensus Revenue Estimate is $483.13M (+74.9% Y/Y). Over the last 2 yea...
NORTHAMPTON, MA / ACCESSWIRE / July 24, 2023 / Alkermes is honored to be selected for the Bell Seal for Workplace Mental Health at Platinum for the second consecutive year. This award, given annually by Mental Health America recognizes our commitment to fostering a mentally healthy workplace. ...
Alkermes to Report Second Quarter Financial Results on July 26, 2023 PR Newswire DUBLIN , July 19, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...